The Ministry of health has established criteria for evaluating a lean health clinics

The introduction of a new model of medical institutions based on the principles of lean production, will be judged on 22 criteria. About it informs TASS.

The Ministry of health has prepared a draft of the order in which the medical organization, introducing a new model, divided into three levels. In hospitals of the first level should be a separate sick and healthy patients, and should not be crossed more than once the recipient of the services of OMS for their money.

On the second level of the medical organization of primary care should not only provide criteria for the first level, but at the same time to increase the number of scheduled patients at the outpatient clinic by appointment up to 70%, as well as to organize not less than 50% of the record without going into the registry. It is envisaged at this level and “complete at least one project for improvement of the medical organization Director of the medical organization and his deputies”.

At the third level, according to the draft order, the medical organization must already comply with the requirements of the first and second levels, and to increase the number of patients by appointment and without a treatment in the registry, to increase the digitalization of the medical institution, otherwise to plan for stocks of medical devices and medicines in the offices and warehouses.

Leave a Reply

Your email address will not be published. Required fields are marked *


The total number of deaths from coronavirus, has exceeded 700,000

Worldwide, the number of deaths from coronavirus infection was over 700,000. Leaders in deaths from COVID-19 were the United States, Brazil, India and Mexico. Approximately 24 hours from the coronavirus dies 5900 people, is about 247 people every hour, or 1 person in 15 seconds, according to Reuters.

Microgen expands production of preparations for allergen-specific immunotherapy

Scientific-production Association “Microgen” has concluded the agreement with JSC “Biomed” them. I. I. Mechnikov (member of JSC “Pharmstandard”) about acquisition of rights on 31 name of diagnostic and therapeutic allergens. This will allow you to organize in Russia the production of new drugs against allergies on the advanced technology. Following the transaction, the company’s portfolio […]